Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (NsPFA) Technology to Be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting

HAYWARD, Calif.--(BUSINESS WIRE)--May 16, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, toda

Pulse BiosciencesMay 15 23:00

Pulse Biosciences Names a New CEO With Former Boss Moving to CCO Role

MassDeviceMay 15 13:26

Pulse Biosciences Welcomes New President and CEO Barrett

TipRanksMay 15 08:22

Pulse Biosciences: Danahy Will Now Lead the Pilot Launch of the Recently FDA Cleared CellFX NsPFA Percutaneous Electrode System

Pulse Biosciences: Danahy Will Now Lead the Pilot Launch of the Recently FDA Cleared CellFX NsPFA Percutaneous Electrode System

Dow JonesMay 14 15:07

Pulse Biosciences Names Burke T. Barrett as President and CEO >PLSE

Pulse Biosciences Names Burke T. Barrett as President and CEO >PLSE

Dow JonesMay 14 15:06

Pulse Biosciences Enhances Executive Leadership Team

Appoints proven atrial fibrillation medical technology leader Burke T. Barrettas President and Chief Executive Officer Former President and Chief Executive Officer Kevin Danahy appointed as Chief Comm

Pulse BiosciencesMay 13 23:00